Click Here to return To Results

 

Randomized, Comparative Study of Interferon B-1a Treatment Regimens in MS Neurol 59:1496-1506,1482, Panitch,H.,et al, 2002 See this aricle in Pubmed Article Abstract IFN¯-1a 44 ug subcutaneously tiw was more effective than IFNB-1a 30 ug IM qw on all primary and secondary outcomes investigated after 24 and 48 weeks of treatment.

Related Tags

(click to filter results - removes previous filter) EVIDENCE trial interferon interferon beta 1-a multiple sclerosis multiple sclerosis,relapsing multiple sclerosis,treatment of treatment of neurologic disorder

Click Here to return To Results